Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Hollander

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Postgraduate Medicine|December 1, 1995
New oral agents for type II diabetes. Taking a more aggressive approach to therapyP A Hollander
Postgraduate Medicine|August 12, 2009
Current trends in treating type 2 diabetesP A Hollander
Medicine and Science in Sports and Exercise|August 17, 1999
Physical performance in persons with spinal cord injuries after discharge from rehabilitationA J Dallmeijer, L H van der Woude, P A Hollander, et al.
Diabetes Care|May 26, 2001
Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetesP A Hollander, S L Schwartz, M R Gatlin, et al.
Diabetes Care|August 14, 1998
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind studyP A Hollander, S C Elbein, I B Hirsch, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Postgraduate Medicine|December 1, 1995
New oral agents for type II diabetes. Taking a more aggressive approach to therapyP A Hollander
Postgraduate Medicine|August 12, 2009
Current trends in treating type 2 diabetesP A Hollander
Medicine and Science in Sports and Exercise|August 17, 1999
Physical performance in persons with spinal cord injuries after discharge from rehabilitationA J Dallmeijer, L H van der Woude, P A Hollander, et al.
Diabetes Care|May 26, 2001
Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetesP A Hollander, S L Schwartz, M R Gatlin, et al.
Diabetes Care|August 14, 1998
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind studyP A Hollander, S C Elbein, I B Hirsch, et al.
Pageof 1